Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury

Biochemical Journal

Volumn 416, Issue 3, 2008, Pages 337-346

  Mayoral, Rafael ^a,b   Mollá, Belen ^a,b   Flores, Juana Maria ^c   Boscá, Lisardo ^a,b   Casado, Marta ^a,b   Martín Sanz, Paloma ^a,b  

^a CSIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Concanavalin A; Inflammation; Lipopolysaccharide; Prostaglandins

Indexed keywords

APOPTOSIS; CONCANAVALIN A; INFLAMMATION; LIPOPOLYSACCHARIDE; PROSTAGLANDINS;

ANIMALS; CELL DEATH; LIVER; PATHOLOGY; POLYSACCHARIDES; PROTEINS;

PH EFFECTS;

ADENYLATE KINASE; AMINOTRANSFERASE; CONCANAVALIN A; CYCLIN D1; CYCLIN E; CYCLINE; CYCLOOXYGENASE 2; GALACTOSAMINE; LIPOPOLYSACCHARIDE; PROCASPASE 3; PROCASPASE 8; PROSTAGLANDIN E2; PROTEIN KINASE B; BIOLOGICAL MARKER; CASPASE; CYTOKINE; PROSTAGLANDIN; PTGS2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HEPATITIS; INFLAMMATION; LIVER CELL; LIVER INJURY; LIVER PROTECTION; LIVER REGENERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN FUNCTION; TRANSGENIC MOUSE; ANIMAL; APOPTOSIS; BLOOD; C57BL MOUSE; CELL LINE; CYTOLOGY; DBA MOUSE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LIVER; LIVER RESECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENE;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CASPASES; CELL LINE; CELL PROLIFERATION; CONCANAVALIN A; CYCLOOXYGENASE 2; CYTOKINES; GALACTOSAMINE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATECTOMY; HEPATOCYTES; HUMANS; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; PROSTAGLANDINS; TRANSGENES;

EID: 58949101853     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20081224     Document Type: Article

References (45)

1. Avila, M. A., Berasain, C., Sangro, B. and Prieto, J. (2006) New therapies for hepatocellular carcinoma. Oncogene 25, 3866-3884
2. Simmons, D. L., Botting, R. M. and Hla, T. (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 56, 387-437
3. Pilbeam, C. C., Kawaguchi, H., Hakeda, Y., Voznesensky, O., Alander, C. B. and Raisz, L. G. (1993) Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268, 25643-25649
4. Feng, L., Xia, Y., Garcia, G. E., Hwang, D. and Wilson, C. B. (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J. Clin. Invest. 95, 1669-1675
5. Martin-Sanz, P., Callejas, N. A., Casado, M., Diaz-Guerra, M. J. and Bosca, L. (1998) Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. Br. J. Pharmacol. 125, 1313-1319
6. Ledwith, B. J., Pauley, C. J., Wagner, L. K., Rokos, C. L., Alberts, D. W. and Manam, S. (1997) Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells. J. Biol. Chem. 272, 3707-3714
7. Casado, M., Callejas, N. A., Rodrigo, J., Zhao, X., Dey, S. K., Bosca, L. and Martin-Sanz, P. (2001) Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J. 15, 2016-2018
8. Fernandez-Martinez, A., Callejas, N. A., Casado, M., Bosca, L. and Martin-Sanz, P. (2004) Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes. J. Hepatol. 40, 963-970
9. Yamamoto, H., Kondo, M., Nakamori, S., Nagano, H., Wakasa, K., Sugita, Y., Chang-De, J., Kobayashi, S., Damdinsuren, B., Dono, K. et al. (2003) JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis 1. Gastroenterology 125, 556-571
10. Lara-Pezzi, E., Gomez-Gaviro, M. V., Galvez, B. G., Mira, E., Iniguez, M. A., Fresno, M., Martinez, A. C., Arroyo, A. G. and Lopez-Cabrera, M. (2002) The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 110, 1831-1838
11. Nunez, O., Fernandez-Martinez, A., Majano, P. L., Apolinario, A., Gomez-Gonzalo, M., Benedicto, I., Lopez-Cabrera, M., Bosca, L., Clemente, G., Garcia-Monzon, C. and Martin-Sanz, P. (2004) Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 53, 1665-1672
12. Kern, M. A., Schubert, D., Sahi, D., Schoneweiss, M. M., Moll, I., Haugg, A. M., Dienes, H. P., Breuhahn, K. and Schirmacher, P. (2002) Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology 36, 885-894
13. Morinaga, S., Yamamoto, Y., Noguchi, Y., Imada, T., Rino, Y., Akaike, M., Sugimasa, Y., Takemiya, S., Kameda, Y. and Takanashi, Y. (2002) Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma. J. Gastroenterol. Hepatol. 17, 1110-1116
14. Canbay, A., Friedman, S. and Gores, G. J. (2004) Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39, 273-278
15. Casado, M., Molla, B., Roy, R., Fernandez-Martinez, A., Cucarella, C., Mayoral, R., Bosca, L. and Martin-Sanz, P. (2007) Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. Hepatology 45, 631-638
16. Gilroy, D. W. and Colville-Nash, P. R. (2000) New insights into the role of COX 2 in inflammation. J. Mol. Med. 78, 121-129
17. Kuzumoto, Y., Sho, M., Ikeda, N., Hamada, K., Mizuno, T., Akashi, S., Tsurui, Y., Kashizuka, H., Nomi, T., Kubo, A. et al. (2005) Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice. Hepatology 42, 608-617
18. Riendeau, D., Percival, M. D., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Falgueyret, J. P., Ford-Hutchinson, A. W. et al. (1997) Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol. 121, 105-117
19. Trautwein, C., Rakemann, T., Brenner, D. A., Streetz, K., Licato, L., Manns, M. P. and Tiegs, G. (1998) Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 114, 1035-1045
20. Fernandez-Martinez, A., Molla, B., Mayoral, R., Bosca, L., Casado, M. and Martin-Sanz, P. (2006) Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells. Biochem. J. 398, 371-380
21. Nowak, M., Gaines, G. C., Rosenberg, J., Minter, R., Bahjat, F. R., Rectenwald, J., MacKay, S. L., Edwards, 3rd, C. K. and Moldawer, L. L. (2000) LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R1202-R1209
22. Hsu, H., Shu, H. B., Pan, M. G. and Goeddel, D. V. (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308
23. Maeda, S., Chang, L., Li, Z. W., Luo, J. L., Leffert, H. and Karin, M. (2003) IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725-737
24. van der Poll, T., Coyle, S. M., Kumar, A., Barbosa, K., Agosti, J. M. and Lowry, S. F. (1997) Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor. J. Immunol. 158, 1490-1497
25. Li, X., Yang, Y. and Ashwell, J. D. (2002) TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345-347
26. Tiegs, G., Hentschel, J. and Wendel, A. (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196-203
27. Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V. A. and Gao, B. (2002) Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110, 1503-1513
28. Kim, R., Emi, M., Tanabe, K. and Arihiro, K. (2006) Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 66, 5527-5536
29. Callejas, N. A., Bosca, L., Williams, C. S., Du, B. R. and Martin-Sanz, P. (2000) Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins. Gastroenterology 119, 493-501
30. Yu, J., Hui, A. Y., Chu, E. S., Cheng, A. S., Go, M. Y., Chan, H. L., Leung, W. K., Cheung, K. F., Ching, A. K., Chui, Y. L. et al. (2007) Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis. Gut 56, 991-999
31. Takano, M., Nishimura, H., Kimura, Y., Washizu, J., Mokuno, Y., Nimura, Y. and Yoshikai, Y. (1998) Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice. J. Immunol. 161, 3019-3025
32. Treffkorn, L., Scheibe, R., Maruyama, T. and Dieter, P. (2004) PGE2 exerts its effect on the LPS-induced release of TNF-α, ET-1, IL-1α, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages. Prostaglandins Other Lipid Mediat. 74, 113-123
33. 2-dependent inhibition of the hepatocyte's acute phase response. Hepatology 31, 1128-1134
34. 2 mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury. Hepatology 45, 159-169
35. Liu, C. H., Chang, S. H., Narko, K., Trifan, O. C., Wu, M. T., Smith, E., Haudenschild, C., Lane, T. F. and Hla, T. (2001) Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem. 276, 18563-18569
36. Oshima, H., Oshima, M., Inaba, K. and Taketo, M. M. (2004) Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J. 23, 1669-1678
37. Leng, J., Han, C., Demetris, A. J., Michalopoulos, G. K. and Wu, T. (2003) Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 38, 756-768
38. Tsujii, M. and DuBois, R. N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501
39. Lin, M. T., Lee, R. C., Yang, P. C., Ho, F. M. and Kuo, M. L. (2001) Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 276, 48997-49002
40. Buchanan, F. G. and DuBois, R. N. (2006) Connecting COX-2 and Wnt in cancer. Cancer Cell 9, 6-8
41. Schulze-Bergkamen, H., Brenner, D., Krueger, A., Suess, D., Fas, S. C., Frey, C. R., Dax, A., Zink, D., Buchler, P., Muller, M. and Krammer, P. H. (2004) Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 39, 645-654
42. Havel, P. J. (2004) Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 53, Suppl 1, S143-S151
43. Rudnick, D. A., Perlmutter, D. H. and Muglia, L. J. (2001) Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc. Natl. Acad. Sci. U.S.A. 98, 8885-8890
44. Shao, J., Jung, C., Liu, C. and Sheng, H. (2005) Prostaglandin E2 stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J. Biol. Chem. 280, 26565-26572
45. Amaravadi, R. and Thompson, C. B. (2005) The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 115, 2618-2624